<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35000003</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1076</ISSN><JournalIssue CitedMedium="Internet"><Volume>181</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>European journal of pediatrics</Title><ISOAbbreviation>Eur J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.</ArticleTitle><Pagination><StartPage>1597</StartPage><EndPage>1607</EndPage><MedlinePgn>1597-1607</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00431-021-04345-z</ELocationID><Abstract><AbstractText Label="UNLABELLED">Most children have a mild course of acute COVID-19. Only few mainly non-controlled studies with small sample size have evaluated long-term recovery from SARS-CoV-2 infection in children. The aim of this study was to evaluate symptoms and duration of 'long COVID' in children. A nationwide cohort study of 37,522 children aged 0-17&#xa0;years with RT-PCR verified SARS-CoV-2 infection (response rate 44.9%) and a control group of 78,037 children (response rate 21.3%). An electronic questionnaire was sent to all children from March 24th until May 9th, 2021. Symptoms lasting&#x2009;&gt;&#x2009;4&#xa0;weeks were common among both SARS-CoV-2 children and controls. However, SARS-CoV-2 children aged 6-17&#xa0;years reported symptoms more frequently than the control group (percent difference 0.8%). The most reported symptoms among pre-school children were fatigue Risk Difference (RD) 0.05 (CI 0.04-0.06), loss of smell RD 0.01 (CI 0.01-0.01), loss of taste RD 0.01 (CI 0.01-0.02) and muscle weakness RD 0.01 (CI 0.00-0.01). Among school children the most significant symptoms were loss of smell RD 0.12 (CI 0.12-0.13), loss of taste RD 0.10 (CI 0.09-0.10), fatigue RD 0.05 (CI 0.05-0.06), respiratory problems RD 0.03 (CI 0.03-0.04), dizziness RD 0.02 (CI 0.02-0.03), muscle weakness RD 0.02 (CI 0.01-0.02) and chest pain RD 0.01 (CI 0.01-0.01). Children in the control group experienced significantly more concentration difficulties, headache, muscle and joint pain, cough, nausea, diarrhea and fever than SARS-CoV-2 infected. In most children 'long COVID' symptoms resolved within 1-5&#xa0;months.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Long COVID in children&#xa0;is rare and mainly of short duration.</AbstractText><AbstractText Label="WHAT IS KNOWN" NlmCategory="BACKGROUND">&#x2022; There are increasing reports on 'long COVID' in adults. &#x2022; Only few studies have evaluated the long-term recovery from COVID-19 in children, and common for all studies is a small sample size (median number of children included 330), and most lack a control group.</AbstractText><AbstractText Label="WHAT IS NEW" NlmCategory="BACKGROUND">&#x2022; 0.8% of SARS-CoV-2 positive children reported symptoms lasting &gt;4 weeks ('long COVID'), when compared to a control group. &#x2022; The most common 'long COVID' symptoms were fatigue, loss of smell and loss of taste, dizziness, muscle weakness, chest pain and respiratory problems. &#x2022; These 'long COVID' symptoms cannot be assigned to psychological sequelae of social restrictions. &#x2022; Symptoms such as concentration difficulties, headache, muscle- and joint pain as well as nausea are not 'long COVID' symptoms. &#x2022; In most cases 'long COVID' symptoms resolve within 1-5 months.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borch</LastName><ForeName>Luise</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1054-0601</Identifier><AffiliationInfo><Affiliation>Department of Pediatric and Adolescent Medicine, NIDO Denmark, Hospitalsenheden Vest, Gl. Landevej 61, 7400, Herning, Denmark. luise.borch@rm.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holm</LastName><ForeName>Mette</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knudsen</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit of Clinical Biostatistics, Aalborg University Hospital, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellermann-Eriksen</LastName><ForeName>Svend</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagstroem</LastName><ForeName>Soeren</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Aalborg University Hospital, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Pediatr</MedlineTA><NlmUniqueID>7603873</NlmUniqueID><ISSNLinking>0340-6199</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Long-term recovery</Keyword><Keyword MajorTopicYN="N">Sars-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>9</Day><Hour>21</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35000003</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pii">10.1007/s00431-021-04345-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Swann OV, Holden KA, Turtle L, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020;370:m3249. doi: 10.1136/bmj.m3249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3249</ArticleId><ArticleId IdType="pmc">PMC7488201</ArticleId><ArticleId IdType="pubmed">32960186</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020 doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugentlige opg&#xf8;relser med overv&#xe5;gningsdata. https://covid19.ssi.dk/overvagningsdata/ugentlige-opgorelser-med-overvaagningsdata. Accessed 10 Apr 2021</Citation></Reference><Reference><Citation>EpiCentro COVID-19 integrated surveillance data in Italy. https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-dashboard. Accessed 10 Apr 2021</Citation></Reference><Reference><Citation>CDC (2020) COVID data tracker. Cent Dis Control Prev. https://covid.cdc.gov/covid-data-tracker. Accessed 10 Apr 2021</Citation></Reference><Reference><Citation>Hartling UB, Holm M, Glenthoej JP, et al. The need for hospitalization due to SARS-CoV-2 in children: a population-based estimate. Pediatr Infect Dis J. 2021;40:e250&#x2013;e251. doi: 10.1097/INF.0000000000003127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003127</ArticleId><ArticleId IdType="pubmed">33956760</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhopal SS, Bagaria J, Olabi B, Bhopal R. Children and young people remain at low risk of COVID-19 mortality. Lancet Child Adolesc Health. 2021 doi: 10.1016/S2352-4642(21)00066-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00066-3</ArticleId><ArticleId IdType="pmc">PMC7946566</ArticleId><ArticleId IdType="pubmed">33713603</ArticleId></ArticleIdList></Reference><Reference><Citation>(2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Excellence (UK), London</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I, H&#xe4;llqvist J, Gilmour KC et al (2020) The long tail of Covid-19 - the detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research 9:1349. 10.12688/f1000research.27287.2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(21)00211-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Pujol FE, Munblit D et al (2021) Clinical characteristics, activity levels and mental health problems in children with long COVID: a survey of 510 children. 10.20944/preprints202103.0271.v1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenburg J, Wekenborg MK, Reichert J et al (2021) Mental health of adolescents in the pandemic: long-COVID19 or long-pandemic syndrome?</Citation></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, et al. (2021) Preliminary evidence on long COVID in children. Acta Paediatr Oslo Nor. 1992;110:2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Brackel CLH, Lap CR, Buddingh EP, et al. Pediatric long-COVID: an overlooked phenomenon? Pediatr Pulmonol. 2021;56:2495&#x2013;2502. doi: 10.1002/ppul.25521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25521</ArticleId><ArticleId IdType="pmc">PMC8242715</ArticleId><ArticleId IdType="pubmed">34102037</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021 doi: 10.1001/jama.2021.11880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021 doi: 10.1016/S2352-4642(21)00198-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Shafran R, De Stavola B, et al. Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study) BMJ Open. 2021;11:e052838. doi: 10.1136/bmjopen-2021-052838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-052838</ArticleId><ArticleId IdType="pmc">PMC8392739</ArticleId><ArticleId IdType="pubmed">34446502</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterky E, Olsson-&#xc5;kefeldt S, Hertting O, et al. (2021) Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta Paediatr Oslo Nor. 1992;110:2578&#x2013;2580. doi: 10.1111/apa.15999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15999</ArticleId><ArticleId IdType="pmc">PMC8444740</ArticleId><ArticleId IdType="pubmed">34157167</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazi-Hoffnung L, Shmueli E, Ehrlich S, et al. Long COVID in children: observations from a designated pediatric clinic. Pediatr Infect Dis J. 2021 doi: 10.1097/INF.0000000000003285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003285</ArticleId><ArticleId IdType="pmc">PMC8575093</ArticleId><ArticleId IdType="pubmed">34371507</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P et al (2021) Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J 2101341.&#xa0;10.1183/13993003.01341-2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D, Crawford N, McNab S, et al. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. 2021;5:e22&#x2013;e23. doi: 10.1016/S2352-4642(21)00124-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00124-3</ArticleId><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Smane L, Roge I, Pucuka Z, Pavare J. Clinical features of pediatric post-acute COVID-19: a descriptive retrospective follow-up study. Ital J Pediatr. 2021;47:177. doi: 10.1186/s13052-021-01127-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01127-z</ArticleId><ArticleId IdType="pmc">PMC8390049</ArticleId><ArticleId IdType="pubmed">34446085</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Nemati H, Shahisavandi M, et al. Long COVID in children and adolescents. World J Pediatr WJP. 2021;17:495&#x2013;499. doi: 10.1007/s12519-021-00457-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39:22&#x2013;25. doi: 10.1177/1403494810387965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1403494810387965</ArticleId><ArticleId IdType="pubmed">21775345</ArticleId></ArticleIdList></Reference><Reference><Citation>Allgaier A-K, Pietsch K, Fr&#xfc;he B, et al. Depression in pediatric care: is the WHO-Five Well-Being Index a valid screening instrument for children and adolescents? Gen Hosp Psychiatry. 2012;34:234&#x2013;241. doi: 10.1016/j.genhosppsych.2012.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2012.01.007</ArticleId><ArticleId IdType="pubmed">22325631</ArticleId></ArticleIdList></Reference><Reference><Citation>Loades ME, Chatburn E, Higson-Sweeney N, et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020;59:1218&#x2013;1239.e3. doi: 10.1016/j.jaac.2020.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaac.2020.05.009</ArticleId><ArticleId IdType="pmc">PMC7267797</ArticleId><ArticleId IdType="pubmed">32504808</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller F, Nguyen V, Navaratnam AM et al (2021) Prevalence of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and Wales</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9645448</ArticleId><ArticleId IdType="pubmed">36375098</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. 2021 doi: 10.1097/INF.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar L, Kahlon N, Jain A, et al. Loss of smell and taste in COVID-19 infection in adolescents. Int J Pediatr Otorhinolaryngol. 2021;142:110626. doi: 10.1016/j.ijporl.2021.110626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2021.110626</ArticleId><ArticleId IdType="pmc">PMC7804378</ArticleId><ArticleId IdType="pubmed">33477014</ArticleId></ArticleIdList></Reference><Reference><Citation>Balfour HH, Odumade OA, Schmeling DO, et al. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis. 2013;207:80&#x2013;88. doi: 10.1093/infdis/jis646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis646</ArticleId><ArticleId IdType="pmc">PMC3523797</ArticleId><ArticleId IdType="pubmed">23100562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF. (2021) Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr Oslo Nor. 1992;110:914&#x2013;921. doi: 10.1111/apa.15673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh DK, Foley DA, Minney-Smith CA, et al. The impact of COVID-19 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020 doi: 10.1093/cid/ciaa1475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1475</ArticleId><ArticleId IdType="pmc">PMC7543326</ArticleId><ArticleId IdType="pubmed">32986804</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang QS, Wood T, Jelley L et al (2021) Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun 12.&#xa0;10.1038/s41467-021-21157-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881137</ArticleId><ArticleId IdType="pubmed">33579926</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, Rose CD et al (2021) Preliminary evidence on long COVID in children. medRxiv 2021.01.23.21250375. 10.1101/2021.01.23.21250375</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Stringhini S, Wisniak A, Piumatti G, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet Lond Engl. 2020;396:313&#x2013;319. doi: 10.1016/S0140-6736(20)31304-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31304-0</ArticleId><ArticleId IdType="pmc">PMC7289564</ArticleId><ArticleId IdType="pubmed">32534626</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>